Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04548375 · ClinicalTrials.gov registry record
Multicenter Outcome Registry of AnaLgesic Effect of SCS(MORALES) Registry Protocol
A clinical trial of SCS, sponsored by Cardio Surgical Partners.
- Recruiting
- Registry status
- 500
- Enrollment target
- 1
- Study location
NCT04548375: Recruiting study of SCS, sponsored by Cardio Surgical Partners.
NCT04548375 is a study of SCS that is actively recruiting participants, run by Cardio Surgical Partners. The registered enrollment target is 500 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04548375, a study of SCS, is actively recruiting participants, sponsored by Cardio Surgical Partners.
- RECRUITING
- Registry status
- 500 participants
- Enrollment target
- 1
- Study location
Study Summary
The objective is to provide information to help the physician community decide the most effective type of device/therapy that would work for their patients, based off of the etiology of pain, the location of the pain for sustained pain relief.
Primary Outcome
Percent of patient who show a change in Pain Scale (PIPS) \>50% at the end of follow up period of 12 months
Conditions Studied
Interventions
- DEVICE SCS
Study Locations (1)
Nevada
- Summit Surgery Center - Reno
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 500 participants |
| Start Date | 2020-11-01 |
| Est. Completion | 2026-11-01 |
What NCT04548375 shows while recruiting
NCT04548375 is an observational study that tracks outcomes without assigning an intervention. The registered 500 participants enrollment target is mid-sized for trials with a published cap.
The record links to 1 condition, with SCS appearing as the primary indexed condition, and to 1 intervention - of which SCS is the first listed.
NCT04548375 reports a single indexed study location in Nevada.
Frequently Asked Questions
What is clinical trial NCT04548375 about?
NCT04548375 is a clinical study titled "Multicenter Outcome Registry of AnaLgesic Effect of SCS(MORALES) Registry Protocol". The objective is to provide information to help the physician community decide the most effective type of device/therapy that would work for their patients, based off of the etiology of pain, the location of the pain for sustained pain relief.
What is the current status of trial NCT04548375?
This trial is currently recruiting. The enrollment target is 500 participants. The study started on 2020-11-01. Estimated completion is 2026-11-01.
What conditions does trial NCT04548375 study?
This clinical trial studies the following conditions: SCS.
What interventions are being tested in trial NCT04548375?
The interventions under investigation include: SCS (DEVICE).
Who is sponsoring clinical trial NCT04548375?
This trial is sponsored by Cardio Surgical Partners, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04548375 being conducted?
This trial has 1 study location across Nevada. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for SCS
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00001230 · 500 participants
Host Response to Infection and Treatment in Filarial Diseases
- NCT00001529 · 500 participants
Improved Methods of Cell Selection for Bone Marrow Transplant Alternatives
- NCT00697411 · 500 participants
Study of Selected X-Linked Disorders: Aicardi Syndrome
- NCT00903110 · 500 participants
Global Patient Registry to Monitor Long-term Safety and Effectiveness of Increlex® in Children and Adolescents With Severe Primary Insulin-like Growth Factor-1 Deficiency (SPIGFD).
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI